Interestingly, multiple studies have confirmed that Icaritin, the classic active compound of EPE, can promote CD8+ T cell infiltration and enhance the anti-tumor immune effects of PD-1 inhibitors (Li et al., 2022; Xu et al., 2024). This evidence concerns the gene CD8A and neoplasm.